Basic loss per share was computed by dividing net loss by the weighted-average number of Common Shares outstanding for each respective period. Diluted loss per share was calculated by dividing net loss by the weighted-average of all potentially dilutive Common Shares that were outstanding during the periods presented. However, for all periods in which the Company recognized a net loss, the Company did not recognize the effect of the potential dilutive securities as their inclusion would be anti-dilutive. Potential dilutive shares of 414,075 and 187,351 for the three months ended June 30, 2026 and 2025, respectively, were excluded from diluted loss per share because the effect would be anti-dilutive. Potential dilutive shares of 454,123 and 149,292 for the six months ended June 30, 2026 and 2025, respectively, were excluded from diluted loss per share because the effect would be anti-dilutive.


	Three months ended June 30,		Six months ended June 30,
	2026	2025	2026	2025
Basic weighted-average Common Shares outstanding	28,243,855	27,788,367	28,070,817	27,734,145
Effect of dilutive shares	—	—	—	—
Diluted weighted-average Common Shares outstanding	28,243,855	27,788,367	28,070,817	27,734,145

There were 535,556 and 972,099 performance-based right to receive Common Shares outstanding at June 30, 2026 and 2025, respectively. The right to receive Common Shares are included in the computation of diluted earnings per share, to the extent they are not anti-dilutive, based on the number of Common Shares that would be issuable if the end of the quarter were the end of the performance period.